Royal Prima PT (JK:PRIM) — Market Cap & Net Worth
Market Cap & Net Worth: Royal Prima PT (PRIM)
Royal Prima PT (JK:PRIM) has a market capitalization of $16.43 Million (Rp280.40 Billion) as of May 3, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #25610 globally and #570 in its home market, demonstrating a 5.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Royal Prima PT's stock price Rp83.00 by its total outstanding shares 3378320205 (3.38 Billion). Analyse Royal Prima PT cash flow conversion to see how efficiently the company converts income to cash.
Royal Prima PT Market Cap History: 2018 to 2026
Royal Prima PT's market capitalization history from 2018 to 2026. Data shows change from $119.76 Million to $16.43 Million (-24.15% CAGR).
Index Memberships
Royal Prima PT is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$540.85 Billion | 0.00% | #557 of 864 |
Weight: Royal Prima PT's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Royal Prima PT Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Royal Prima PT's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Royal Prima PT's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $119.76 Million | $204.79 Billion | $17.21 Billion | 0.00x | 0.01x |
| 2019 | $83.14 Million | $174.22 Billion | $2.40 Billion | 0.00x | 0.03x |
| 2020 | $45.93 Million | $260.59 Billion | $38.17 Billion | 0.00x | 0.00x |
| 2021 | $79.18 Million | $599.96 Billion | $75.43 Billion | 0.00x | 0.00x |
| 2022 | $34.25 Million | $261.93 Billion | $21.59 Billion | 0.00x | 0.00x |
| 2023 | $17.42 Million | $265.34 Billion | -$2.75 Billion | 0.00x | N/A |
| 2024 | $11.09 Million | $299.36 Billion | -$18.41 Billion | 0.00x | N/A |
Competitor Companies of PRIM by Market Capitalization
Companies near Royal Prima PT in the global market cap rankings as of May 3, 2026.
Key companies related to Royal Prima PT by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Royal Prima PT Historical Marketcap From 2018 to 2026
Between 2018 and today, Royal Prima PT's market cap moved from $119.76 Million to $ 16.43 Million, with a yearly change of -24.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp16.43 Million | 0.00% |
| 2025 | Rp16.43 Million | +48.21% |
| 2024 | Rp11.09 Million | -36.36% |
| 2023 | Rp17.42 Million | -49.13% |
| 2022 | Rp34.25 Million | -56.75% |
| 2021 | Rp79.18 Million | +72.41% |
| 2020 | Rp45.93 Million | -44.76% |
| 2019 | Rp83.14 Million | -30.58% |
| 2018 | Rp119.76 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Royal Prima PT was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.43 Million USD |
| MoneyControl | $16.43 Million USD |
| MarketWatch | $16.43 Million USD |
| marketcap.company | $16.43 Million USD |
| Reuters | $16.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Royal Prima PT
PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more